IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy

Biomaterials

Volumn 34, Issue 28, 2013, Pages 6853-6861

  Yue, Caixia ^a   Liu, Peng ^a   Zheng, Mingbin ^a,b   Zhao, Pengfei ^a   Wang, Yiqing ^a   Ma, Yifan ^a   Cai, Lintao ^a  

^a SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Drug delivery; Heparin; Imaging analysis; Laser ablation; Nanoparticle

Indexed keywords

CELL VIABILITY ASSAYS; FLUORESCENCE INTENSITIES; HEPARIN; IMAGING ANALYSIS; MOLECULAR TARGETING; NEAR-INFRARED FLUORESCENCE; PHOTOTHERMAL THERAPY; THERANOSTIC AGENTS;

DRUG DELIVERY; EXPERIMENTS; FLUORESCENCE; INFRARED DEVICES; LASER ABLATION; NANOPARTICLES; ORGANIC ACIDS; POLYSACCHARIDES; TUMORS;

SYNTHESIS (CHEMICAL);

DYE; IR 780 DYE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; ENCAPSULATION; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LASER; LIPOPHILICITY; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PHOTOTHERAPY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TEMPERATURE MEASUREMENT; TUMOR VOLUME; TUMOR XENOGRAFT; ZETA POTENTIAL;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INDOLES; MICE; MICE, NUDE; NANOPARTICLES; PHOTOTHERAPY;

EID: 84879463079     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.05.071     Document Type: Article

References (33)

1. Mahounga D.M., Shan L., Jie C., Du C., Wan S., Gu Y. Synthesis of a novel l-methyl-methionine ICG-der-02 fluorescent probe for invivo near infrared imaging of tumors. Mol Imaging Biol 2012, 14:699-707.
2. Zhang P., Liu S., Gao D., Hu D., Gong P., Sheng Z., et al. Click-functionalized compact quantum dots protected by multidentate-imidazole ligands: conjugation-ready nanotags for living-virus labeling and imaging. JAm Chem Soc 2012, 134:8388-8391.
3. Zheng C., Zheng M., Gong P., Jia D., Zhang P., Shi B., et al. Indocyanine green-loaded biodegradable tumor targeting nanoprobes for invitro and invivo imaging. Biomaterials 2012, 33:5603-5609.
4. Zheng M., Yue C., Ma Y., Gong P., Zhao P., Zheng C., et al. Single-step assembly of DOX/ICG loaded lipid polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano 2013, 7:2056-2067.
5. Smith B.A., Gammon S.T., Xiao S., Wang W., Chapman S., McDermott R., et al. Invivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe. Mol Pharm 2011, 8:583-590.
6. Zhang C., Wang S., Xiao J., Tan X., Zhu Y., Su Y., et al. Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye. Biomaterials 2010, 31:1911-1917.
7. Peng C.L., Shih Y.H., Lee P.C., Hsieh T.M., Luo T.Y., Shieh M.J. Multimodal image-guided photothermal therapy mediated by 188Re-labeled micelles containing a cyanine-type photosensitizer. ACS Nano 2011, 5:5594-5607.
8. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.T., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
9. Chen J., Glaus C., Laforest R., Zhang Q., Yang M., Gidding M., et al. Gold nanocages as photothermal transducers for cancer treatment. Small 2010, 6:811-817.
10. Wang X., Wang C., Cheng L., Lee S.T., Liu Z. Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy. JAm Chem Soc 2012, 134:7414-7422.
11. Liu X., Tao H., Yang K., Zhang S., Lee S.T., Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for invivo photothermal ablation of tumors. Biomaterials 2011, 32:144-151.
12. Yang K., Wan J., Zhang S., Tian B., Zhang Y., Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 2012, 33:2206-2214.
13. Zhou M., Zhang R., Huang M., Lu W., Song S., Melancon M.P., et al. Achelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. JAm Chem Soc 2010, 132:15351-15358.
14. Sharifi S., Behzadi S., Laurent S., Forrest M.L., Stroeve P., Mahmoudi M. Toxicity of nanomaterials. Chem Soc Rev 2012, 41:2323-2343.
15. Lovell J.F., Jin C.S., Huynh E., Jin H., Kim C., Rubinstein J.L., et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater 2011, 10:324-332.
16. Yang K., Xu H., Cheng L., Sun C., Wang J., Liu Z. Invitro and invivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles. Adv Mater 2012, 24:5586-5592.
17. Cheng L., Yang K., Chen Q., Liu Z. Organic stealth nanoparticles for highly effective invivo near-infrared photothermal therapy of cancer. ACS Nano 2012, 6:5605-5613.
18. She W., Li N., Luo K., Guo C., Wang G., Geng Y., et al. Dendronized heparin doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy. Biomaterials 2013, 34:2252-2264.
19. Park J.W., Jeon O.C., Kim S.K., Al-Hilal T.A., Jin S.J., Moon H.T., et al. High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives. JControl Release 2010, 148:317-326.
20. Lee D.Y., Kim S.K., Kim Y.S., Son D.H., Nam J.H., Kim I.S., et al. Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate. JControl Release 2007, 118:310-317.
21. Kim J.Y., Shim G., Choi H.W., Park J., Chung S.W., Kim S., et al. Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex. Biomaterials 2012, 33:4424-4430.
22. Park K., Lee G.Y., Kim Y.S., Yu M., Park R.W., Kim I.S., et al. Heparin deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. JControl Release 2006, 114:300-306.
23. Park K., Kim Y.S., Lee G.Y., Park R.W., Kim I.S., Kim S.Y., et al. Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth. Pharm Res 2008, 25:2786-2798.
24. Wang X., Li J., Wang Y., Cho K.J., Kim G., Gjyrezi A., et al. HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano 2009, 3:3165-3174.
25. Kalli K.R., Oberg A.L., Keeney G.L., Christianson T.J., Low P.S., Knutson K.L., et al. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecol Oncol 2008, 108:619-626.
26. Kalli K.R., Dainty L.A., Risinger J.I., Morrison C., Chandramouli G.V., Bidus M.A., et al. Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma. Gynecol Oncol 2007, 105:563-570.
27. Saba N.F., Wang X., Müller S., Tighiouart M., Cho K., Nie S., et al. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug. Head Neck 2009, 31:475-481.
28. Hartmann L.C., Keeney G.L., Lingle W.L., Christianson T.J., Varghese B., Hillman D., et al. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer 2007, 121:938-942.
29. Iwakiri S., Sonobe M., Nagai S., Hirata T., Wada H., Miyahara R. Expression status of folate receptor is significantly correlated with prognosis in non-small-cell lung cancers. Ann Surg Oncol 2008, 15:889-899.
30. Lim Y.T., Noh Y.W., Han J.H., Cai Q.Y., Yoon K.H., Chung B.H. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. Small 2008, 4:1640-1645.
31. Li J.P. Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?. Anticancer Agents Med Chem 2008, 8:64-76.
32. Heneweer C., Gendy S.E., Penate-Medina O. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging. Ther Deliv 2012, 3:645-656.
33. Zhang J., Jin W., Wang X., Wang J., Zhang X., Zhang Q. Anovel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. Mol Pharm 2010, 7:1159-1168.